Oren Livnat

Stock Analyst at HC Wainwright & Co.

(3.68)
# 751
Out of 4,893 analysts
140
Total ratings
45.14%
Success rate
8.18%
Average return

Stocks Rated by Oren Livnat

Pacira BioSciences
Apr 8, 2025
Maintains: Buy
Price Target: $48$65
Current: $23.71
Upside: +174.15%
Verrica Pharmaceuticals
Apr 8, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.87
Upside: -
Collegium Pharmaceutical
Mar 24, 2025
Reiterates: Buy
Price Target: $50
Current: $33.03
Upside: +51.38%
Trevi Therapeutics
Mar 19, 2025
Reiterates: Buy
Price Target: $13
Current: $6.41
Upside: +95.01%
ANI Pharmaceuticals
Mar 17, 2025
Reiterates: Buy
Price Target: $94
Current: $66.14
Upside: +42.12%
Zevra Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $20
Current: $12.02
Upside: +66.39%
Jazz Pharmaceuticals
Mar 10, 2025
Maintains: Buy
Price Target: $200$217
Current: $112.48
Upside: +92.92%
Xeris Biopharma Holdings
Mar 7, 2025
Reiterates: Buy
Price Target: $6.6$8
Current: $5.27
Upside: +51.80%
Avadel Pharmaceuticals
Mar 4, 2025
Reiterates: Buy
Price Target: $21
Current: $9.77
Upside: +114.94%
Tarsus Pharmaceuticals
Feb 26, 2025
Reiterates: Buy
Price Target: $73
Current: $41.10
Upside: +77.62%
Reiterates: Buy
Price Target: $12
Current: $3.10
Upside: +287.10%
Reiterates: Buy
Price Target: $7.5
Current: $3.80
Upside: +97.37%
Maintains: Buy
Price Target: $14$8
Current: $0.70
Upside: +1,042.86%
Maintains: Buy
Price Target: $43$60
Current: $3.32
Upside: +1,692.17%
Maintains: Buy
Price Target: $252$198
Current: $1.38
Upside: +14,247.83%